RecruitingNot ApplicableNCT06751056

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Neck Traction to Reduce Gabaergic Medication Use for Neuropathic Itch- A Pilot Study

Sponsor

Mayo Clinic

Enrollment

12 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Pruritus

Summary

The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Cervical Traction Device for people with pruritus. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECervical Traction Device

Participants will use their home neck traction devices daily for 12 weeks, while continuing their prescriptions for gabapentin or pregabalin. At study initiation and every 2 weeks thereafter for a total of 12 weeks, they will receive an electronic survey assessing their itch score. Based on survey results, they will receive a call from the study team to adjust their dosage of gabapentin or pregabalin by up to 33%.